Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ARGAN INC Director's Dealing 2021

Apr 28, 2021

31210_dirs_2021-04-28_92bb589b-42fc-408a-a552-cd74eb524714.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARGAN INC (AGX)
CIK: 0000100591
Period of Report: 2021-04-26

Reporting Person: Koilpillai Mano S (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-04-26 Common Stock M 2631 $40.15 Acquired 2631 Direct
2021-04-26 Common Stock S 2631 $50.16 Disposed 0 Direct
2021-04-27 Common Stock M 702 $40.15 Acquired 702 Direct
2021-04-27 Common Stock S 522 $49.94 Disposed 180 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-04-26 Stock Option to Purchase Common Stock $40.15 M 2631 Disposed 2029-12-23 Common Stock (2631) Direct
2021-04-27 Stock Option to Purchase Common Stock $40.15 M 702 Disposed 2029-12-23 Common Stock (702) Direct

Footnotes

F1: On April 26, 2021, the Reporting Person exercised her stock option received on December 23, 2019 to purchase 2,631 shares of the Issuer's common stock at a price of $40.15 per share.

F2: On April 26, 2021, the Reporting Person sold 2,631 shares of common stock on the open market at an average price of $50.16 per share.

F3: On April 27, 2021, the Reporting Person exercised her stock option received on December 23, 20219 to purchase 702 shares of the Issuer's common stock at a price of $40.15 per share.

F4: On April 27, 2021 the Reporting Person sold 522 shares of common stock on the open market at an average price of $49.94 per share.

F5: As of the date of this filing, the Reporting Person owns options to purchase (a) 10,000 shares of common stock at a price of $42.31 per share with initial Date Exercisable of 9/10/2020 and Expiration Date of 9/10/2029; (b) 6,667 shares of common stock at a price of $40.15 per share with initial Date Exercisable of 12/23/2020 and Expiration Date of 12/23/2029; and (c) 10,000 shares of common stock at a price of $45.75 per share with initial Date Exercisable of 12/14/2021 and Expiration Date of 12/14/2030, all of which vest ratably over three years on the anniversary of each grant date.